Combination Formulation Containing Sustained Release Metformin And Immediate Release HMG-COA Reductase Inhibitor

The present invention relates to a complex formulation containing metformin used in the treatment of non-insulin dependent diabetes and an HMG-CoA reductase inhibitor used in the treatment of dyslipidemia. The present invention provides a complex formulation and a method for preparing the complex fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yoon, Seok Kee, Kang, Kwi Man, Lee, Ji Eun, Cho, Tae Keun, Park, Jun Hong, Kim, Yu Jeong, Oh, Tack Oon, Park, Young Joon
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a complex formulation containing metformin used in the treatment of non-insulin dependent diabetes and an HMG-CoA reductase inhibitor used in the treatment of dyslipidemia. The present invention provides a complex formulation and a method for preparing the complex formulation, wherein the complex formulation contains metformin and an HMG-CoA reductase inhibitor, and has effectively improved stability by securing the stable release of respective active ingredients and blocking physical and chemical reactions between the active ingredients.